Exciting News from HT-Advance!  We're thrilled to announce that the first patient had been included in the HT-PREDICT study end of May 2024, marking a significant milestone for our consortium. 🌟 Radboudumc has led the way by successfully enrolling the first patient, setting the stage for a promising journey ahead. A special shoutout to @Joost [...]